Stock Research for ZIOP


Featured Broker: Ally Invest

Get the due diligence for another stock.


ZIOP Stock Chart & Research Data

The ZIOP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ZIOP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ZIOP Due diligence Resources & Stock Charts

The ZIOP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ZIOP Detailed Price Forecast - CNN Money CNN View ZIOP Detailed Summary - Google Finance
Yahoo View ZIOP Detailed Summary - Yahoo! Finance Zacks View ZIOP Stock Research & Analysis -

Stock Analysis

TradeIdeas View ZIOP Trends & Analysis - Trade-Ideas Barrons View ZIOP Major Holders - Barrons
NASDAQ View ZIOP Call Transcripts - NASDAQ Seeking View ZIOP Breaking News & Analysis - Seeking Alpha
Spotlight View ZIOP Annual Report - OTC Report View ZIOP OTC Short Report -
TradeKing View ZIOP Fundamentals - TradeKing Charts View ZIOP SEC Filings - Bar Chart
WSJ View Historical Prices for ZIOP - The WSJ Morningstar View Performance/Total Return for ZIOP - Morningstar
MarketWatch View the Analyst Estimates for ZIOP - MarketWatch CNBC View the Earnings History for ZIOP - CNBC
StockMarketWatch View the ZIOP Earnings - StockMarketWatch MacroAxis View ZIOP Buy or Sell Recommendations - MacroAxis
Bullish View the ZIOP Bullish Patterns - American Bulls Short Pains View ZIOP Short Pain Metrics -

Social Media Mentions

StockTwits View ZIOP Stock Mentions - StockTwits PennyStocks View ZIOP Stock Mentions - PennyStockTweets
Twitter View ZIOP Stock Mentions - Twitter Invest Hub View ZIOP Investment Forum News - Investor Hub
Yahoo View ZIOP Stock Mentions - Yahoo! Message Board Seeking Alpha View ZIOP Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ZIOP - Insider Cow View Insider Transactions for ZIOP - Insider Cow
CNBC View ZIOP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ZIOP - OTC Markets
Yahoo View Insider Transactions for ZIOP - Yahoo! Finance NASDAQ View Institutional Holdings for ZIOP - NASDAQ

Stock Charts

FinViz View ZIOP Stock Insight & Charts - StockCharts View ZIOP Investment Charts -
BarChart View ZIOP Stock Overview & Charts - BarChart Trading View View ZIOP User Generated Charts - Trading View

Latest Financial News for ZIOP

Biotech Stocks on the Move
Posted on Monday January 21, 2019

HENDERSON, NV / ACCESSWIRE / January 21, 2019 / Biotech has been one of the hottest sectors this month. Investors are intrigued by the increase in M&A. Now's a great time to start researching some oversold ...

Ziopharm Oncology Posts Letter to Stockholders
Posted on Monday January 07, 2019

The new license agreement helped pave the way for us to raise $50 million in a private placement from existing investors, secure a clinical collaboration with Regeneron Pharmaceuticals for Controlled IL-12 and announce a joint venture with committed funding of up to $35 million to bring our Sleeping Beauty platform for CD19-specific CAR-T to China. As we begin 2019, Ziopharm is already better.

Ziopharm Oncology (ZIOP) in Focus: Stock Moves 6.2% Higher
Posted on Friday December 28, 2018

Ziopharm Oncology (ZIOP) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets
Posted on Thursday December 27, 2018

Ziopharm Oncology, Inc. (ZIOP) today responded to the recent decline in the Company’s stock price, which accelerated greatly on December 26, 2018, the same day that the broader market and all indexes were up significantly. To the extent this price drop may have been attributable to any market confusion over exclusivity to its assets, the Company wishes to make clear the terms of its exclusivity to such assets. “Our stock price is significantly down of late, and we want to assure the market that our business fundamentals are unchanged and we are optimistic about Ziopharm’s future especially in light of the recent announcements we made with regards to our restructured relationship with Intrexon, the securing of a clean and longer-term balance sheet, and two partnerships with Regeneron and Eden BioCell.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.